HemoCD as a Totally Synthetic Artificial Oxygen Carrier: Improvements in the Synthesis and O2/CO Discrimination
HemoCD, which is composed of an iron(II)porphyrin such as 5,10,15,20‐tetrakis(4‐sulfonatophenyl)porphinatoiron(II) (Fe(II)TPPS) and a cyclodextrin (CD) dimer having a pyridine linker, represents a synthetic hemoglobin (Hb) model compound that exhibits reversible oxygen (O2) binding ability in aqueou...
Saved in:
Published in | Artificial organs Vol. 41; no. 4; pp. 372 - 380 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Geesthacht
Wiley Subscription Services, Inc
01.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | HemoCD, which is composed of an iron(II)porphyrin such as 5,10,15,20‐tetrakis(4‐sulfonatophenyl)porphinatoiron(II) (Fe(II)TPPS) and a cyclodextrin (CD) dimer having a pyridine linker, represents a synthetic hemoglobin (Hb) model compound that exhibits reversible oxygen (O2) binding ability in aqueous solution at an ambient temperature. Therefore, hemoCD has the potential to be used as a totally synthetic artificial oxygen carrier. In this article, we describe the improvements of hemoCD related to its synthesis and O2/CO selectivity. The synthesis procedure of the CD dimer of hemoCD was re‐examined, and the CD dimer was successively synthesized from inexpensive β‐CD with a 38% yield (three‐steps), which enabled us to obtain the CD dimer in gram‐quantities. The O2/CO selectivity of hemoCD was also markedly improved using an iron(II)porphyrin having a carboxylate group at the distal site of hemoCD. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0160-564X 1525-1594 |
DOI: | 10.1111/aor.12870 |